Analyst Expectations For Sage Therapeutics's Future
Analyst Expectations For Sage Therapeutics's Future
分析师对sage therapeutics未来的预期
The perception of Sage Therapeutics by financial experts...In the last three months, 20 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE), offering a diverse range of perspectives from bullish to bearish.
在过去的三个月里，20位分析师对Sage Therapeutics（纳斯达克：SAGE）进行了评级，提供了从看好到看淡的多样化观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $19.35, a high estimate of $28.00, and a low estimate of $8.00. This current average has decreased by 23.46% from the previous average price target of $25.28.
分析师12个月的价格目标的洞察被揭示出来，提供的平均目标为19.35美元，最高估计为28.00美元，最低估计为8.00美元。当前平均目标从先前的25.28美元的平均目标下降了23.46%。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析：详细分析
The perception of Sage Therapeutics by financial experts...
通过最近的分析师...
登录免费看全文
登录/注册